1.
Faunce TA, Johnston K, Bambrick H. The Trans-Tasman Therapeutic Products Authority: Potential AUSFTA Impacts on Safety and Cost-Effectiveness Regulation for Medicines and Medical Devices in New Zealand. VUWLR [Internet]. 2006 Sep. 1 [cited 2022 Aug. 14];37(3):365-90. Available from: https://ojs.victoria.ac.nz/vuwlr/article/view/5574